Skip to content

Lymphatic Morphology of Fontan Patients

Lymphatic Morphology and Classification in Patients With a Fontan Circulation - A Multicenter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04163653
Enrollment
41
Registered
2019-11-15
Start date
2018-01-01
Completion date
2022-01-01
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphatic Abnormality, Plastic Bronchitis, Protein-Losing Enteropathies, Univentricular Heart, Congenital Heart Disease

Brief summary

The Fontan procedure has revolutionized the treatment of patients born with a congenital univentricular heart defect. However, over time, it is associated with severe lymphatic complications such as plastic bronchitis, protein-losing enteropathy (PLE) and peripheral edema. The hypothesis is that patients with a univentricular circulation have a changed morphology which may be associated with both the degree of lymphatic complications and their physical capacity. The morphology will be described using T2-weighted non-contrast MRI.

Detailed description

The Fontan procedure has revolutionized the treatment of patients born with a congenital univentricular heart defect. However, over time, it is associated with severe lymphatic complications such as plastic bronchitis, protein-losing enteropathy (PLE) and peripheral edema. It has been proposed that these complications arise due to a elevated central venous pressure of the changed circulation. The hypothesis of the study is that patients with a univentricular circulation have a changed morphology which may be associated with both the degree of lymphatic complications and their physical capacity. The morphology will be described using T2-weighted non-contrast MRI. The main lymphatic vessel, the thoracic duct, will be rendered and measured using 3D software, and the lymphatic changes characterized by Dr. Yoav Dori (CHOP, Pennsylvania, USA), using a newly published grading system. The above will be correlated with the amount of complications experienced by the patients, and their physical capacity measured by both IPAQ questionaire and CPX test. The study population consists of patients with a Fontan circulation operated at InCor Heart Institute, São Paulo, Brasil and Hospital das Clínicas, Ribeirão Preto, Brasil. Exclusion criteria were mental illness, genetic syndromes and age \<18 years. The patient group will be compared with age, gender and weight matched healthy controls.

Interventions

DIAGNOSTIC_TESTNon-contrast MRI

Classification and characterization of the lymphatic vasculature using non-contrast MRI.

DIAGNOSTIC_TESTCardiopulmonary exercise test

Cardiopulmonary exercise test, measurement of VO2 and heart rate.

Sponsors

InCor Heart Institute
CollaboratorOTHER
Hospital das Clínicas de Ribeirão Preto
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

\- Fontan Circulation

Exclusion criteria

* Age \<18 years * Mental illness * Genetic syndromes

Design outcomes

Primary

MeasureTime frameDescription
Lymphatic classification1 hourClassified by third party, according to following: (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542623/)
Relative measure of tortuosity1 hourStraight length/full length (mm/mm)
Measurement of thoracic duct volume1 hourVolume (mm\^2)
Measurement of thoracic duct diameter1 hourDiameter at inlet (mm)
The International Physical Activity Questionnaire (IPAQ-SF)1 hourIPAQ-SF estimation of weekly activity. (Total Physical Activity min/wk: 2 × time spent on vigorous + moderate + walking) Higher value equals higher level of activity.
CPX heart rate1 hourMaximum heart rate (bpm)
CPX Vo21 hourVO2 max

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026